We’re excited to introduce theCONFORM Trial SmartBRIEF— a monthly email dedicated to keeping you informed and set up for success. Each issue will feature key trial updates, tips and best practices, site highlights, and more to support your work on CONFORM.
As we move closer to our CE Mark submission milestone, the strength of our clinical data is key to showcasing the safety and effectiveness of the CLAAS® AcuFORM™ device. We appreciate your continued partnership in keeping subject data current — from image uploads to closing out any open queries.
A quick look through the database to tidy up any remaining items will help ensure we stay aligned and on schedule. Your site manager and/or monitor will be in touch to support you and share anything that still needs attention.
Thank you for everything you’re doing to help bring this important therapy to patients.
This past week, Dr. William Gray, System Chief of the Division of Cardiovascular Disease at Main Line Health, presented the latest on CLAAS® AcuFORM™ technology and the CONFORM Trial. He highlighted encouraging clinical experience to date, noting the next-generation device has been easy to size, easy to verify, and easy to seal.
Dr. Gray and the TCT panel also recognized Conformal for our strong commitment to patient safety and clinical integrity — a core principle that drives our work.
We are excited to share with you that we have developed a new tool to help assist Research Coordinators in communicating the benefits of the CONFORM Pivotal Trial with the CLAAS AcuFORM LAAO device.
This new guide is desinged to assist you in answering questions your patients may have about participating in a clinical study. Be on the lookout for this piece to be released the week of November 17th on the RC portal and the CONFORM App.
The CLAAS® AcuFORM™ System is limited by federal law (United States) to investigational use. Exclusively for clinical investigation outside the United States. Not approved for commercial use.
DISCLAIMER:The information contained in this email (including any file attachments transmitted with it) is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorised review, use, alteration, disclosure, copying or distribution is prohibited. If you have received this email in error, please notify the sender by return email and destroy all copies of the original message. Any confidentiality or privilege is not waived or lost by any mistaken delivery of this email.
Conformal Medical, 15 Trafalgar Square, Suite 101, Nashua, NH 03063, USA
.png?upscale=true&width=520&upscale=true&name=Conformal%20Logo%20-%20Wordmark%20(Inverse%2c%20RGB).png)
